Care Pathways

17.05.18

UK risks being ‘second-tier state’ for drugs without post-Brexit EMA deal, MPs say

The government must “protect the UK’s status as a world leader for pharmaceuticals” in a future made uncertain by the ongoing Brexit negotiations, MPs have said today.

A report released by the Business, Energy and Industrial Strategy Committee (BEIS) argued that leaving the European Union without an agreement for the industry would diminish access to markets that bring £11.9bn of worth of exports to the economy and significantly impact the cost of drugs imported in from the EU.

No deal between both sides would risk a “hugely damaging effect” on the procurement of drugs coming in from the EU, of which the Union supplies almost three-quarters of the nation’s entire drug imports demanded by Brits.

The MPs said: “As a highly-regulated industry, the prospect of regulator divergence from the European Medicines Agency (EMA) is the deepest concern for the industry. Without a continued relationship, there is a significant risk of the UK being a second-tier state for new and innovative medicines.

“There are no benefits from regulatory divergence and no prospect of the industry being able to fully manage any divergence required in the time available for transition,” the report wrote.

If the UK departs from EMA regulations, the committee claimed the release of a new drug could cost as much as £45,000, putting the nation’s attractiveness for top pharmaceutical companies and professionals in doubt.

MPs called upon the government to keep the UK in the EMA as a priority when entering the Brexit negotiations. They concluded: “We have sought out any potential benefits to the UK pharmaceutical sector from Brexit, but found that any small gains would be hugely outweighed by additional costs or the loss of access to existing, successful markets.

“The best potential we found for the UK to remain and grow as a world leader in the development, manufacture and regulation of pharmaceuticals is to maintain as close as possible a relationship with the EU as possible.”

Rachel Reeves MP, chair of the BEIS Committee, said: “The government’s own analysis identifies pharmaceuticals as the sector for which UK/EU market access is the most important given the industry is reliant on friction-free border movement for their products. Any delays at the border faced by short-life pharmaceuticals for emergency treatments would have a hugely detrimental impact on patients.

“Some form of membership of the EMA is vital to the continued success of the pharma industry and to the welfare of British patients, and the government should strike a deal to keep some of the organisation’s jobs and facilities in the UK, to continue to share our world-leading expertise.”

Peter Ballard, chair of the British Generic Manufacturers Association, said the organisation fully supports the report’s key finding that Whitehall must secure a post-Brexit deal for the pharma industry “ensuring the closest possible regulatory alignment with the EU and the minimum border friction possible,” or else it risks harming patients.

“There is a real risk that the UK becomes a second tier country behind the US and the EU with the launch of new medicines being delayed due to different regulatory rules,” he concluded.

Image Credit: artisteer, iStock images

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

Two NHS trusts spent a third of the year on highest ‘Opel 4’ pressure alert

12/12/2018Two NHS trusts spent a third of the year on highest ‘Opel 4’ pressure alert

Two NHS trusts spent more than a third of the year under extreme pressure and on the highest level of alert. An investigation by the BBC fou... more >
Financially struggling NHS trust appoints fifth chief executive in just five years

12/12/2018Financially struggling NHS trust appoints fifth chief executive in just five years

The financially troubled West Hertfordshire Hospitals NHS Trust has appointed Christen Allen as its newest chief executive – marking its fi... more >
Quarter of trusts spent no money on cyber security last year as NHS’s ‘alarming’ cyber training inconsistencies revealed

12/12/2018Quarter of trusts spent no money on cyber security last year as NHS’s ‘alarming’ cyber training inconsistencies revealed

One in four NHS trusts in England and Wales are spending no money on specialist cyber security or training and trusts are consistently failing to... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

The robots are here at East Suffolk and North Essex

12/12/2018The robots are here at East Suffolk and North Essex

Lauren Hockney, senior communications officer at East Suffolk and North Essex NHS FT (ESNEFT), outlines how her trust is embracing the digital and automation revolution. Robots have arrived at the ESNEFT, and they are giving back hundreds of hours to staff so they can spend more time helping patients. The trust, which includes Colche... more >
read more blog posts from 'the scalpel' >

comment

Creating a volunteer 'passport'

12/12/2018Creating a volunteer 'passport'

By utilising the health service’s volunteers, we can deliver better care for everyone, argues Kay Fawcett OBE, clinical project lead at Hel... more >
Right people, right place, right now

12/12/2018Right people, right place, right now

Sean Duggan, chief executive of the Mental Health Network, raises concerns around the mental health workforce and shares some best practice from ... more >
Breaking down barriers to integration

12/12/2018Breaking down barriers to integration

Anne Marie Morris, member of the Public Accounts Committee (PAC) and MP for Newton Abbott, outlines the committee’s recent report on the ba... more >
An attack on them is an attack on us all

12/12/2018An attack on them is an attack on us all

Chris Bryant MP discusses the new law he championed that came into effect in September, which doubles jail time for anyone who assaults emergency... more >

interviews

How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >
Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >

health service focus

View all News